Latest Recipharm News & Updates

See the latest news and media coverage for Recipharm. We track all announcements, press releases, and industry mentions in real time, all in one place.

Recipharm

CDMO for pharmaceuticals and biologics

recipharm.com

Headquarters: Baar, Switzerland
Founded year: 1995
Company type: Private company
Number of employees: 3,100–5,000
Industry: Pharmaceuticals

Last updated October 4

Latest news about Recipharm

In short: Recipharm refinanced debt, appointed Greg Behar CEO, relocated HQ and restructured manufacturing

Company announcements

April 16 Recipharm

Recipharm receives CEPI seed funding for Analysis Zero

The funding supports development of NMR-based real-time PAT to monitor RNA vaccine CQAs, aiming to accelerate batch release, reduce costs and improve global vaccine access.

April 15 Recipharm

Recipharm publishes 2025 sustainability report

It highlights 20% Scope 1 and 74% Scope 2 emissions reductions, 100% renewable electricity, and strong CDP scores. They partner with customers to cut Scope 3 emissions.

April 8 Recipharm

Recipharm reports strong 2025 sustainability performance

Earned B for Climate Change, A- for Water Security, A for Supplier Engagement from CDP. Cut Scope 1 emissions 20%, Scope 2 74% vs 2021.

March 2 Recipharm

Recipharm announces technical seminar series to FDA

The series focuses on next-generation testing with PAT and 'lab on wheels' at Watertown Center of Excellence.

Media coverage

October 4 Pharmaceutical Technology

A Productive Day: Recipharm Completes Two Biologics Deals | Pharmaceutical Commerce

CDMO obtains both Vibalogics and Arranta Bio to increase presence in the sector...

Never miss news about Recipharm

Track Recipharm and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Recipharm competitors & trending companies

Browse news for competitors to Recipharm and other trending companies.